PEMOA37 | Vaccine scheme, age and previous COVID-19 predict humoral response to SARS-CoV-2 vaccination in HIV-infected indivudals | Poster exhibition | SARS-Cov2 vaccines |
PEMOA38 | People living with HIV who are receiving suppressive antiretroviral therapy mount strong humoral responses to two and three doses of COVID-19 vaccine | Poster exhibition | SARS-Cov2 vaccines |
PEMOB27 | Persistent low-level viremia in the era of dolutegravir in four African countries | Poster exhibition | Adherence |
PEMOB28 | Safety outcomes among HIV-1 positive Zambian adults receiving Tenofovir Alafenamide combined with Dolutegravir: results from the VISEND clinical trial | Poster exhibition | Pregnancy (clinical management issues and pharmacokinetics) and contraception |
PEMOB29 | Selection of cabotegravir dosing regimens for HIV treatment and pre-exposure prophylaxis (PrEP) in adolescents by Leveraging adult data | Poster exhibition | Pharmacokinetics/pharmacodynamics/pharmacogenomics and therapeutic drug monitoring in paediatric and adolescent populations |
PEMOB30 | Optimizing DTG uptake amongst children living with HIV in Ikom rural communities attending ART clinic at Comprehensive Health Center (CHC) Ikom, Cross River State | Poster exhibition | ARV management strategies in paediatric and adolescent populations |
PEMOB31 | The cognitive development of children born to adolescent mothers ' does child HIV status matter? | Poster exhibition | Mental health and neurocognition in paediatric and adolescent populations |
PEMOB32 | No difference in prevalence of TB infection among infants in two Southern African cohorts by in utero HIV exposure status | Poster exhibition | HIV-exposed uninfected children |
PEMOB33 | Causes of death and hospitalisations in a cohort of sex workers in South Africa | Poster exhibition | Clinical issues in sex workers |
PEMOB34 | Prevalence and risk factors for anal dysplasia among men who have sex with men living with HIV: the HPV Screening and Vaccine Evaluation (HPV-SAVE) Study | Poster exhibition | Malignancies (AIDS and non-AIDS) |